tiprankstipranks
Trending News
More News >
Evotec Ag (Adr) (EVO)
:EVO
US Market

Evotec AG (EVO) Stock Forecast & Price Target

Compare
198 Followers
See the Price Targets and Ratings of:

EVO Financial Forecast

EVO Earnings Forecast

The previous quarter’s earnings for EVO were -$0.12.
The previous quarter’s earnings for EVO were -$0.12.

EVO Sales Forecast

The previous quarter’s earnings for EVO were $203.11M.
The previous quarter’s earnings for EVO were $203.11M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$8
Buy
151.57%
Upside
Reiterated
11/07/24
Evotec AG's Strategic Growth and Financial Outlook Justifies Buy Rating Amidst Market Challenges
TD Cowen
$10
Buy
214.47%
Upside
Reiterated
11/06/24
Evotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic Initiatives
Jefferies
$8.7$3.8
Hold
19.50%
Upside
Downgraded
10/07/24
Evotec downgraded to Hold from Buy at JefferiesEvotec downgraded to Hold from Buy at Jefferies
Bank of America Securities
$4.5$3
Sell
-5.66%
Downside
Reiterated
08/14/24
Analysts Offer Insights on Healthcare Companies: Evotec AG (NASDAQ: EVO), Medtronic (NYSE: MDT) and Cardinal Health (NYSE: CAH)
Morgan Stanley
$31.81$13.63
Hold
328.67%
Upside
Downgraded
07/29/24
Evotec downgraded to Equal Weight from Overweight at Morgan StanleyEvotec downgraded to Equal Weight from Overweight at Morgan Stanley
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$8
Buy
151.57%
Upside
Reiterated
11/07/24
Evotec AG's Strategic Growth and Financial Outlook Justifies Buy Rating Amidst Market Challenges
TD Cowen
$10
Buy
214.47%
Upside
Reiterated
11/06/24
Evotec AG: Buy Rating Affirmed Amid Promising Growth Prospects and Strategic Initiatives
Jefferies
$8.7$3.8
Hold
19.50%
Upside
Downgraded
10/07/24
Evotec downgraded to Hold from Buy at JefferiesEvotec downgraded to Hold from Buy at Jefferies
Bank of America Securities
$4.5$3
Sell
-5.66%
Downside
Reiterated
08/14/24
Analysts Offer Insights on Healthcare Companies: Evotec AG (NASDAQ: EVO), Medtronic (NYSE: MDT) and Cardinal Health (NYSE: CAH)
Morgan Stanley
$31.81$13.63
Hold
328.67%
Upside
Downgraded
07/29/24
Evotec downgraded to Equal Weight from Overweight at Morgan StanleyEvotec downgraded to Equal Weight from Overweight at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evotec AG

Which Analyst Should I Follow If I Want to Buy EVO and Sell After:
1 Month
xxx
Success Rate
3/9 ratings generated profit
33%
Average Return
-3.11%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -3.11% per trade.
3 Months
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
+0.60%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of +0.60% per trade.
1 Year
Douglas TsaoH.C. Wainwright
Success Rate
1/9 ratings generated profit
11%
Average Return
-28.43%
reiterated a buy rating 5 months ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -28.43% per trade.
2 Years
xxx
Success Rate
0/9 ratings generated profit
0%
Average Return
-46.01%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -46.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EVO Analyst Recommendation Trends

Rating
Jun 24
Jul 24
Aug 24
Oct 24
Nov 24
Strong Buy
5
2
1
2
4
Buy
1
1
1
0
0
Hold
0
1
1
2
1
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
7
5
4
5
6
In the current month, EVO has received 4 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. EVO average Analyst price target in the past 3 months is $8.00.
Each month's total comprises the sum of three months' worth of ratings.

EVO Stock Forecast FAQ

What is EVO’s average 12-month price target, according to analysts?
Based on analyst ratings, Evotec Ag (Adr)’s 12-month average price target is $8.00.
    What is EVO’s upside potential, based on the analysts’ average price target?
    Evotec Ag (Adr) has 151.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EVO a Buy, Sell or Hold?
          Evotec Ag (Adr) has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Evotec Ag (Adr)’s price target?
            The average price target for Evotec Ag (Adr) is $8.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 151.57% Increase from the current price of $3.18.
              What do analysts say about Evotec Ag (Adr)?
              Evotec Ag (Adr)’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of EVO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis